Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016
K. Suleman, A. Mushtaq, E. Haque, A. Badran, D. Ajarim, T. Tweigeri, A. Elashwah, A. Shahin, K. Khan and A. Alsayed
Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016